Obiettivo
Infections caused by antimicrobial-resistant bacteria (AMRB) account for an increasing proportion of healthcare-associated infections, particularly in high-risk units such as intensive care units and surgery; patients discharged to rehabilitation units often remain carriers of AMRB, contributing to their dissemination into longer-term care areas and within the community.
The overall objective of MOSAR is to gain breakthrough knowledge in the dynamics of transmission of AMRB, and address highly controversial issues by testing strategies to combat the emergence and spread of antimicrobial resistance, focusing on the major and emerging multi-drug antimicrobial resistant microorganisms in hospitals, now spreading into the community. Microbial genomics and human response to carriage of AMRB will be integrated with health sciences research, including interventional controlled studies in diverse hospital settings, mathematical modelling of resistance dynamics, and health economics.
Campo scientifico
- medical and health sciencesclinical medicinephysiotherapy
- medical and health scienceshealth sciences
- medical and health sciencesclinical medicinecritical care medicine
- social scienceseconomics and businesseconomicshealth economics
- medical and health sciencesbasic medicinepharmacology and pharmacydrug resistanceantibiotic resistance
Invito a presentare proposte
FP6-2005-LIFESCIHEALTH-6
Vedi altri progetti per questo bando
Meccanismo di finanziamento
IP - Integrated ProjectCoordinatore
PARIS
Francia
Mostra sulla mappa
Partecipanti (16)
85500 UTRECHT
Mostra sulla mappa
TEL AVIV
Mostra sulla mappa
LONDON
Mostra sulla mappa
CRETEIL
Mostra sulla mappa
105 LE CHESNAY
Mostra sulla mappa
CHILLY MAZARIN
Mostra sulla mappa
1152 LICH
Mostra sulla mappa
CARDIFF
Mostra sulla mappa
HAMBURG
Mostra sulla mappa
GATERSLEBEN
Mostra sulla mappa
GENEVE 4
Mostra sulla mappa